Amyotrophic Lateral Sclerosis (ALS)

VA Biorepository Brain Bank Seeks Veterans with ALS

The U.S. Department of Veterans Affairs (VA) is seeking veterans who have amyotrophic lateral sclerosis (ALS) and who live in the United States to enroll in its VA Biorepository Brain Bank (VABBB), a human tissue bank that collects, processes and stores tissue samples for use in future research studies.

DNA Damage in ALS

A failure to repair damaged DNA appears to play an important role in amyotrophic lateral sclerosis (ALS), an MDA-supported team of researchers reports.

Eighth Annual Tradition of Hope Gala Raises More Than $1.2 Million for MDA's Augie's Quest

ALS Briefs: NurOwn, Disease Modifiers, Biomarker Test

Eighth Annual Tradition Of Hope Gala To Support MDA's Augie's Quest

ALS Briefs: Neuralstem, Body Fat, Behavior, Respiratory Care

This roundup of recent amyotrophic lateral sclerosis (ALS) research and clinical trials news includes:

ALS Briefs: Diet, Autoimmune Disease, ALS TDI, Neuralstem, Cytokinetics

This roundup of recent amyotrophic lateral sclerosis (ALS) research and clinical trials news includes:

ALS Briefs: Protein Clumps, Cell-to-Cell Spread and More

This roundup of recent MDA-supported amyotrophic lateral sclerosis (ALS) research news and reviews includes:

UPDATE: FDA Approves Testing Multiple Sclerosis Drug in ALS

The U.S. Food and Drug Administration (FDA) has given the go-ahead to the nonprofit biotech ALS Therapy Development Institute (ALS TDI) to conduct a clinical trial of TDI132  — also known as fingolimod, or the brand name Gilenya— in people withALS (amyotrophic lateral sclerosis).

National ALS Biorepository Pilot Study Launched

Pages